The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
has caused more than 1 million deaths in the first 6 months of the pandemic and huge …

Abstract Coronavirus disease 2019 (COVID-19) is caused by novel coronavirus Severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first time reported in …

Advances in antiretroviral therapy (ART) have made it possible for persons with human
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …

Purpose Hyperinflammation in severe COVID-19 infection increases the risk of respiratory
failure and one of the cogent reasons of mortality associated with COVID-19. Baricitinib, a …

Recent studies have reported numerous predictors for adverse outcomes in COVID-19
disease. However, there have been few simple clinical risk scores available for prompt risk …

The worldwide pandemic situation of COVID-19 generates a situation in which healthcare
resources such as diagnostic kits, drugs and basic healthcare infrastructure were on …

Background: Endothelial injury can be induced by coronavirus disease 2019 (COVID-19)
and seems to exert a crucial pathogenic role in its most severe clinical manifestations. We …

Since the beginning of the COVID-19 pandemic, numerous variants of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged, including five variants of …

Since the advent of SARS‐CoV‐2, the virus that causes COVID‐19, clinicians have had to
modify how they provide high‐value care while mitigating the risk of viral spread. Routine …

Background Global pandemic identified as coronavirus disease 2019 (COVID-19) has
resulted in a variety of clinical symptoms, from asymptomatic carriers to those with severe …